Backgrounds/Aims: Despite the advances in identifying risk factors, improving operative technique, and postoperative patient care, pancreatic leakage after pancreatic resection remains a highly debated topic. The aim of this study is to describe our technique and our initial experience with the intraoperative embolization of the main pancreatic duct with an Ethylene Vinyl Alcohol Copolymer (Onyx Ⓡ ). Methods: Two patients of 63 and 64 years underwent pancreaticoduodenectomy for a cholangiocarcinoma of the extrahepatic bile duct and a pancreatic adenocarcinoma, respectively. At the time of pancreatic parenchyma resection, a Wirsung duct was identified and catheterized. A wirsungography was done and then, embolization with Onyx Ⓡ was carried out under fluoroscopic control. Results: Neither of the patients developed a postoperative pancreatic fistula. They were discharged to home on the 17 th and 18 th postoperative day, respectively. At the last follow-up, no recurrence was found. The two patients became diabetics; both needed the support of supplementary pancreatic enzymes. Conclusions: To our knowledge, we are the first to describe this technique, which seems safe and reliable. Studies on this subject with more patients are needed to confirm the validity of this procedure. (Ann Hepatobiliary Pancreat Surg 2018;22:248-252)
INTRODUCTION
Post-operative pancreatic fistula (POPF) is the most common and troublesome complication after pancreatic resection, with reported rates ranging from 3% to 45%. [1] [2] [3] It represents the factor most often linked with postoperative complications, longer hospital stays, readmissions, increased costs, and, above all, more postoperative deaths. 4, 5 Despite advances in operative techniques and improvements in postoperative patient care, this subject remains highly debated in the literature. 6 A very controversial issue is the obliteration of the main pancreatic duct with chemicals substances. [7] [8] [9] Numerous substances and techniques have been described with very controversial results. [10] [11] [12] Onyx Ⓡ (Medtronic, Heerlen, the Netherlands) is an liquid agent used for embolization of vascular structures; it consists of an ethylene vinyl alcohol copolymer (EVOH), made opaque with micronized tantalum powder. Onyx Ⓡ provides a good contrast for visualization under fluoroscopy, and so is used especially in the field of vascular interventional radiology 13, 14 but also for bile duct leakage. 15, 16 To the best of our knowledge, the obliteration of the main pancreatic duct with Onyx Ⓡ has not yet been described.
We present our initial technical and clinical experience with two patients who were successfully treated by intraoperative Onyx Ⓡ application.
MATERIALS AND METHODS
Two patients of 63 and 64 years came to our attention for a cholangiocarcinoma of the extrahepatic bile duct and pancreatic adenocarcinoma, respectively. After an accu- (Fig. 1) . After the embolization, the pancreatic extremity was further sectioned using an ECHELON FLEX TM (Ethicon, Cincinnati, OH, USA) stapling device, with a 45-mm white or blue cartridge depending on the thickness of the parenchyma. A hepaticojejunostomy was fashioned using a running 5/0 polydioxanone, and a gastroenterostomy was constructed using an ECHELON FLEX TM stapling device. Drainage was always placed in contact with the sectional pancreatic parenchyma, and two additional drains were placed in the perianastomotic sites.
Postoperative assessment included measurement of drainage and serum amylase on the first, third, and fifth postoperative day. An abdominal computed tomography (CT) scan was performed on the seventh postoperative day, and if no peripancreatic collection was detected, the drainages were removed gradually.
An enteral nutrition tube was placed beyond the gastroenterostomy during surgery, and enteral nutrition was started on the first postoperative day. Subcutaneous octreotide was not administered systematically.
RESULTS
The details of the patients are summarized in Table 1 .
No perioperative complications related to the Onyx Ⓡ About endocrine function, some authors suggest that occlusion of the main pancreatic duct would cause a parenchymal atrophy with a high risk of developing endocrine failure. 21 Tran et al. 8 reported a significantly higher incidence of endocrine insufficiency in the pancreatic duct occlusion group, with a diabetes rate of 34%. In our series, both patients had become diabetic at last examination.
In conclusion, we demonstrate that this approach is feasible and safe; studies with more patients are needed to verify the validity of this technique.
